TickerKhojComparison · NSE · data 2026-11-02
Caplin Point Laboratories Limited vs Cohance Lifesciences Ltd
In plain words
Size: Caplin Point Laboratories Limited is about 1 times the market value of Cohance Lifesciences Ltd.
Valuation (P/E): Cohance Lifesciences Ltd 161.5 vs Caplin Point Laboratories Limited 26.7.
Return on equity: Caplin Point Laboratories Limited 19.9% vs Cohance Lifesciences Ltd 6.4%.
Profit growth over 3 years: Caplin Point Laboratories Limited 19.4% a year vs Cohance Lifesciences Ltd -24.2% a year.
Debt to equity: Cohance Lifesciences Ltd 0.1 vs Caplin Point Laboratories Limited 0.
Differences in the numbers, not a recommendation of either stock.
Side by side
| CAPLIPOINT | COHANCE | |
|---|---|---|
| Price | ₹2,326.2 | ₹445.7 |
| Market cap | ₹17,672 cr | ₹17,005 cr |
| P/E | 26.7 | 161.5 |
| P/B | — | 4.4 |
| ROE | 19.9% | 6.4% |
| ROCE | 20.9% | 4.6% |
| Debt / equity | 0 | 0.1 |
| Operating margin | 31.4% | 5.8% |
| Dividend yield | 0.34% | 0.00% |
| Sales growth, 3 years (yearly) | 14.3% | 19.0% |
| Profit growth, 3 years (yearly) | 19.4% | -24.2% |
| 1-year return | 14.3% | -42.8% |
| Revenue, last 12 months | ₹2,287 cr | ₹2,142 cr |
| Net profit, last 12 months | ₹665 cr | ₹106 cr |
| Latest quarter | Jun 2026 | Jun 2026 |
| Quarter net profit | ₹177 cr | ₹-24 cr |
| Quarter profit vs a year earlier | +15.8% | -149.3% |
| Promoter holding | 70.57% | 57.48% |
| Health check | Strong (7.9/10) | Weak (2.2/10) |
Common questions
Which has a higher P/E, Caplin Point Laboratories Limited or Cohance Lifesciences Ltd?
Cohance Lifesciences Ltd trades at the higher P/E (161.5 against 26.7). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Caplin Point Laboratories Limited (19.9% against 6.4%).
Which carries more debt?
Cohance Lifesciences Ltd has the higher debt-to-equity ratio (0.1 against 0).